Home » Topics » Regulatory » Patents

Patents
RSS

Ohio State University developing AR ablating agents for treating prostate cancer

Oct. 27, 2009

Janssen discloses MC-5 receptor ligands for treatment of dermatological conditions

Oct. 27, 2009

CXCR3 antagonists claimed by sanofi-aventis for rheumatoid arthritis

Oct. 27, 2009

GlaxoSmithKline presents antiviral compounds for HCV infection

Oct. 26, 2009

New glucokinase activators described by Astellas Pharma as antidiabetic agents

Oct. 26, 2009

CGRP antagonists for the treatment of migraine claimed by Merck & Co.

Oct. 26, 2009

University of California claims IRES inhibitors for the treatment of HCV infection

Oct. 23, 2009

Merck KGaA describes glucokinase activators for the treatment of diabetes

Oct. 23, 2009

Boehringer Ingelheim discloses CB2 receptor agonists for the treatment of pain

Oct. 23, 2009

GlaxoSmithKline discovers novel FAK inhibitors for use as oncolytic agents

Oct. 22, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...